Transient exposure to quizartinib mediates sustained inhibition of FLT3 signaling while specifically inducing apoptosis in FLT3-activated leukemia cells von Gunawardane, Ruwanthi N, Nepomuceno, Ronald R, Rooks, Allison M, Hunt, Jeremy P, Ricono, Jill M, Belli, Barbara, Armstrong, Robert C

Volltext

Discovery and optimization of a highly efficacious class of 5-aryl-2-aminopyridines as FMS-like tyrosine kinase 3 (FLT3) inhibitors von Liu, Gang, Abraham, Sunny, Liu, Xing, Xu, Shimin, Rooks, Allison M., Nepomuceno, Ron, Dao, Alan, Brigham, Daniel, Gitnick, Dana, Insko, Darren E., Gardner, Michael F., Zarrinkar, Patrick P., Christopher, Ron, Belli, Barbara, Armstrong, Robert C., Holladay, Mark W.

Volltext

Differential Inhibition of FLT3-ITD, FLT3-WT, and KIT By Quizartinib As Assessed By Modified PIA Assay von Nepomuceno, Ronald, Rooks, Allison M, Gardner, Michael, Armstrong, Robert

Volltext

Detection of Phosphorylated and Total Flt3 and STAT5 in Whole Blood: Modulation by AC220 From Phase I and II Trials in AML von Nepomuceno, Ronald R, Gunawardane, Ruwanthi, Rooks, Allison M, Armstrong, Robert C

Volltext

Abstract 903: AC708 is a potent and selective inhibitor of CSF1R and reduces tumor associated macrophage infiltration in a breast tumor model von Armstrong, Robert C., Belli, Barbara, Rowbottom, Martin W., Nepomuceno, Ron R., Dao, Alan Q., Rooks, Allison M., Brigham, Dan, McMannus, Craig W., Hocker, Michael D., Holladay, Mark W., Liu, Gang

Volltext

Comparative genomics of Shiga toxin encoding bacteriophages von Smith, Darren L, Rooks, David J, Fogg, Paul C M, Darby, Alistair C, Thomson, Nick R, McCarthy, Alan J, Allison, Heather E

Volltext